Feb 4 Myasthenia gravis (MG)

Myasthenia Gravis


Myasthenia gravis (MG) is an autoimmune syndrome caused by the failure of neuromuscular transmission, which results from the binding of autoantibodies to proteins involved in signaling at the neuromuscular junction (NMJ). These proteins include the nicotinic Acetyl Cholinesterase (AChR) or, less frequently, a muscle-specific tyrosine kinase (MuSK). 

To get a free sample report, click the link: https://www.delveinsight.com/report-store/myasthenia-gravis-market-insight-epidemiology-and-market-forecast

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.